5. Polypore International (PPO - Get Report) sells microporous membranes, used in separation and filtration processes, to energy and technology companies. They are utilized in lithium and lead-acid batteries.
12-Month Sales Growth: 17%
12-Month Net Income Growth: -177%
Cash Flow Multiple: 16 (4% peer premium)
Quarterly Operating Profit Margin: 19%
Analyst Opinions: Of analysts evaluating Polypore, six, or 60%, advocate purchasing its shares and four suggest holding them. None are advising clients to sell. Wedbush offers the highest price target, expecting the stock to rise another 19% to $49. JPMorgan rates Polypore "neutral" with a $27 target, suggesting 35% downside. Polypore's forward earnings multiple of 27, book value multiple of 5.4 and sales multiple of 3.1 represent industry premiums.